Solute Carrier Transporters: Structure, Physiology and Pharmacology (D1)
April 13-16, 2026
| Wylie Center and Tupper Manor at Endicott College, Beverly, MA, United States
Giulio Superti-Furga, David Drew and Kathleen Giacomini
Scholarship Deadline: Jan. 8, 2026 | Abstract Deadline: Mar. 24, 2026 | Early Registration Deadline: Feb. 13, 2026
| 4:00–8:00 PM |
Registration |
Conference Center Atrium |
| 6:00–8:00 PM |
Welcome Mixer |
Conference Center Atrium |
| 7:00–8:00 AM |
Breakfast |
Beverly Foyer |
| 7:30–8:00 AM |
Poster Setup |
Ipswich |
| 8:00–8:10 AM |
Welcome Remarks |
Beverly Room |
| 8:09–5:00 PM |
Poster Viewing |
Ipswich |
| 8:10–9:00 AM |
Drs. Edward and Martha Dennis Endowed Keynote Address |
Beverly Room |
| |
Olga Boudker, Weill Cornell Medical College Structure-Function-Mechanism of Neuronal Glutamate Transporters |
|
| 9:00–11:15 AM |
Membrane Transporters and Metabolism |
Beverly Room |
| |
Rajini Rao, Johns Hopkins University Ion Transporters |
|
| |
David Drew, Stockholm University GLUT Transporters |
|
| |
Sarah-Maria Fendt, VIB-KU Leuven Metabolism of Cancer Cells |
|
| |
Daniel Bondeson, UMass Chan Medical School Short Talk: Exploiting Inorganic Phosphate Sensing and Efflux Pathways as Therapeutic Vulnerabilities in Cancer |
|
| 9:30–9:50 AM |
Coffee Break |
Beverly Foyer |
| 11:15–12:15 PM |
Lunch |
Newburyport |
| 11:45–2:00 PM |
Poster Session 1 |
Ipswich |
| 2:00–4:00 PM |
Symposia Spotlight 1: Transporters as Regulators of Cellular Homeostasis |
Beverly Room |
| |
Melinda M Diver, Memorial Sloan Kettering Cancer Center Gatekeepers of Phosphate Homeostasis: Unveiling the Unconventional Mechanism of SLC34 Transporters |
|
| |
Yingze Ma, Johns Hopkins University School of Medicine Dietary Fat Enhances Intestinal Copper Absorption by Modulating Copper Transporter 1 (CTR1/SLC31A1) |
|
| |
Jan Spaas, Stanford University SLC16A13 is a New Pantothenate Transporter linked to Cardiometabolic Disease |
|
| |
Krishna Reddy, University of South Florida Assembly and Biogenesis of an Elevator-Type SLC Transporter |
|
| |
Alastair Stewart, The Victor Chang Cardiac Research Institute Structural Basis of Sodium Ion-Dependent Carnitine Transport by OCTN2 |
|
| |
Peixuan Yu, Michigan State University Structure and Post-Translational Modification of the Prostaglandin Transporter |
|
| |
Daniel Wacker †, Icahn School of Medicine at Mount Sinai Structural Studies Empower the Development of SLC4 (Bi)carbonate Transporter Probes |
|
| |
Eric M. Morrow, Brown University Na+/H+ Exchanger 6 (NHE6) Function in Endosome Maturation and Neurodegeneration |
|
| 4:00–4:30 PM |
Coffee Available |
Beverly Foyer |
| 4:30–6:30 PM |
Transporters and the CNS |
Beverly Room |
| |
Chenghua Gu, Harvard Medical School BBB and Neurotransmitter Transport |
|
| |
Ligong Chen, Tsinghua University An Unconventional and Neglected Iron Transporter in Brain |
|
| |
Laura Cancedda, Istituto Italiano di Tecnologia and IAMA Therapeutics Targeting NKCC Transport Proteins - New Treatments Against CNS Disorders |
|
| |
Dushyant Kumar Srivastava †, Vollum Institute, Oregon Health & Science University Short Talk: Insights into the Allosteric Inhibitory Mechanisms in the Human Dopamine Transporter |
|
| |
Yihan Zhao, Icahn school of medicine at Mount Sinai Short Talk: Rational Design of First In-Class Small Molecule Inhibitors for a Brain Bicarbonate Transporter |
|
| 6:30–9:30 PM |
Transportation to Town for Dinner Options |
|
Wednesday, April 15, 2026
| 7:00–8:00 AM |
Breakfast |
Beverly Foyer |
| 7:30–8:00 AM |
Poster Setup |
Ipswich |
| 8:00–11:00 AM |
Transporter Genetics and Metabolomics |
Beverly Room |
| |
Giulio Superti-Furga, Research Center for Molecular Medicine of the Austrian Academy of Sciences Membrane Transporters as Mediators of Physiology across Cells and Ecosystems |
|
| |
Nora Kory, Harvard T.H Chan School of Public Health Mitochondrial Transporters and the Control of Cellular Metabolism |
|
| |
Nancy Carrasco, Vanderbilt University The Tale of the Sodium/iodide Symporter (NIS): From Cloning to Structure to Engineering |
|
| |
Kim L Brouwer, University of North Carolina at Chapel Hill Bile Acid Metabolism |
|
| |
Joseph R Visker, University of Utah & Wake Forest University Short Talk: Solute-Carrier Bypass for Cardiac Carbohydrate Oxidation Under Stress |
|
| 8:00–5:00 PM |
Poster Viewing |
Ipswich |
| 9:00–9:20 AM |
Coffee Break |
Beverly Foyer |
| 11:00–12:00 PM |
Lunch |
Newburyport |
| 11:30–2:00 PM |
Poster Session 2 |
Ipswich |
| 2:15–3:30 PM |
Career Roundtable |
Beverly Room |
| 3:30–4:00 PM |
Coffee Available |
Beverly Foyer |
| 4:00–6:00 PM |
Integrative Transporter Complexes and Organelles |
Beverly Room |
| |
Simon Newstead, University of Oxford Understanding the Role of SLCs in Chronic Pain in the Human Body |
|
| |
Nicolas Reyes, National Center of Scientific Research Recognition of Solute Carriers by Retrovirus-Derived Human Proteins |
|
| |
Kivanc Birsoy, Rockefeller University Mitochondrial Carrier Physiology |
|
| |
Xujun Cao, Arc Institute Short Talk: Conserved Lysosomal Transporters Regulate cGAMP–STING Signaling by Direct cGAMP Sequestration |
|
| |
Suraj Dasharath Patil †, uniklinik freiburg Short Talk: SLC25A48 Is a Human Mitochondrial Choline Transporter |
|
| 6:00–9:00 PM |
Transportation to Town for Dinner Options |
|
| 7:00–8:00 AM |
Breakfast |
Beverly Foyer |
| 8:00–11:00 AM |
Emerging SLC Technologies for Drug Discovery |
Beverly Room |
| |
Karen Lackey, X-Chem ML-Enabled Drug Discovery Screening |
|
| |
Arturo Molina †, Protagonist Therapeutics Talk Title to be Announced |
|
| |
Erik Lindström, Ipsen Bile Acid Transporters such as SLC10A2 as Target to Treat Liver Disease |
|
| |
Francesca Vallese, City College of New York SLC4A1, the Multitaskerase: from the Ankyrin-1 Complex to CO₂ Transport |
|
| |
Sergei Kutseikin, The Scripps Research Institute Pharmacological Inhibition of SLC33A1 Redefines Its Role in Endoplasmic Reticulum Redox Balance and Adaptive Signaling |
|
| |
Giovanna Maresca, Axxam SpA Short Talk: Advancing KCC2 Pharmacological Potentiation: Breaking the State-of-the-Art for CNS Drug Discovery |
|
| 9:00–9:20 AM |
Coffee Break |
Beverly Foyer |
| 11:00–12:00 PM |
Lunch |
Newburyport |
| 12:00–2:00 PM |
Networking/Social Time |
|
| 2:00–4:00 PM |
Symposia Spotlight 2: Transporters and Cancer |
Beverly Room |
| |
Lior Golomb, Dana-Farber Cancer Institute, Harvard Medical School Inactivation of SLC33A1 Sensitizes EGFR Mutant Lung Cancer Cells to Tyrosine Kinase Inhibition |
|
| |
Gregory S. Ducker, University of Utah An Essential Role for SLC7A5 in Tumor Arginine Metabolism |
|
| |
Rachel (Rae) J House, Van Andel Institute Defining and Targeting Regulators of Lipid Uptake in Cancer |
|
| |
Meinusha Govindarajan, University of Toronto Surface Proteomics Reveals SLC7A1 and Arginine Metabolism as a Vulnerability in High Grade Serous Ovarian Cancer |
|
| |
Ruth H. Palmer †, University of Gothenburg Anaplastic Lymphoma Kinase Harnesses the SLC4A7 Bicarbonate Transporter and De Novo Nucleotide Synthesis in Neuroblastoma and Lung Cancer |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 4:00–4:30 PM |
Coffee Available |
Beverly Foyer |
| 4:30–6:15 PM |
Transporters and Drug Discovery |
Beverly Room |
| |
Kathleen Giacomini, School of Pharmacy, University of California, San Francisco The Pseudogene Divide in the SLC22 Family: From Orphan Genes to Primate-Specific Functions |
|
| |
Christopher G. Parker, The Scripps Research Institute Chemical Proteomic Approaches to Study Transporters |
|
| |
Ariel Bensimon, Solgate Accelerating the Discovery of Drug Candidates Against SLCs |
|
| |
Andreas L Birkenfeld †, Helmholtz Munich Short Talk: First-in-Class Small Molecule Inhibitor of SLC13A5 (INDY) Improves MASH, Hepatic Inflammation and Metabolic Dysregulation in Mice and Human Primary Hepatocytes |
|
| 6:15–6:30 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
Beverly Room |
| 6:30–7:30 PM |
Dinner |
Newburyport |
| 7:30–9:00 PM |
Entertainment |
Beverly Room |